Sunday, 10 Aug 2025
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Subscribe
Life Care News
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
    NewsShow More
    MiTAC Computing Partners with Industry Leaders on Open AI Server Solutions at OCP APAC Summit 2025
    MiTAC Computing Partners with Industry Leaders on Open AI Server Solutions at OCP APAC Summit 2025
    09/08/2025
    NOTICE OF SETTLEMENT APPROVAL
    NOTICE OF SETTLEMENT APPROVAL
    09/08/2025
    BBBS & Israel’s Foresight Awarded USD 5 Million to Build & Commercialize Rugged Autonomous Drones for Hazardous Industrial Environments
    BBBS & Israel’s Foresight Awarded USD 5 Million to Build & Commercialize Rugged Autonomous Drones for Hazardous Industrial Environments
    09/08/2025
    JioStar Presents Bigg Boss 19: A New Season, A New Sarkaar
    JioStar Presents Bigg Boss 19: A New Season, A New Sarkaar
    08/08/2025
    NOTICE OF SETTLEMENT APPROVAL
    Torus Digital enters strategic partnership with Suryoday Small Finance Bank, launches 3-in-1 Savings & Investment Account
    08/08/2025
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
  • 🔥
  • news
  • june
  • july
  • global
  • Business
  • today
  • announced
  • Tech
  • company
  • will
Font ResizerAa
Life Care NewsLife Care News
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Search
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Business

Bonerge Initiates Clinical Trial on Urolithin A and Fisetin for Sleep & Wellbeing

Business Wire
Last updated: 09/07/2025 10:20 AM
Business Wire
Share
3 Min Read
Bonerge Initiates Clinical Trial on Urolithin A and Fisetin for Sleep & Wellbeing
SHARE
Bonerge Initiates Clinical Trial on Urolithin A and Fisetin for Sleep & Wellbeing

NEW YORK–(BUSINESS WIRE)–In 2025, Bonerge initiated a clinical trial (Registration #NCT06990256) investigating the effects of Urolithin A and Fisetin on sleep quality, targeting sleep disorders through the lens of ageing biology.

- Advertisement -




- Advertisement -

This randomized, quadruple-blind (participants, healthcare providers, researchers, assessors), placebo-controlled study will enroll over 80 participants aged 45-70. They will be divided into four groups: Urolithin A alone, Fisetin alone, Urolithin A + Fisetin combination, and placebo control. The 12-week intervention represents the first systematic evaluation of Urolithin A’s potential to resynchronize circadian rhythms and mitigate age-related sleep disturbances.

Key Study Design Features:

- Advertisement -

Inclusion Criteria: Targets subclinical individuals with impaired sleep quality (PSQI score >5) but no pathological diagnosis, excluding those dependent on caffeine/alcohol.

Multidimensional Assessment:

Subjective: Sleep quality scores, chronotype questionnaire, daytime dysfunction scales.

Objective: Continuous actigraphy monitoring, polysomnography (PSG) analysis.

Biomarkers: NAD+ levels, DNA methylation age, inflammatory markers (IL-6, TNF-α), cortisol rhythm, circadian proteins (BMAL1, PER2), insulin resistance (HOMA-IR), immunoglobulin levels.

- Advertisement -

“We aim to uncover the causal link between sleep disorders and ageing using epigenetic clocks and metabolic markers, beyond just tracking sleep duration,” stated Professor Chen, the lead investigator. “Combining Urolithin A, a circadian regulator, with the senolytic Fisetin explores synergy for novel solutions, like menopausal sleep issues.”

Scientific Commitment: Building a Health Ecosystem

- Advertisement -

As a leading high-quality ingredient producer, Bonerge’s R&D follows a pipeline of ‘ingredient science, mechanistic research, clinical translation’. The company is actively seeking global clinical partners from academia and industry to explore Urolithin A’s potential in sleep health and cellular ageing intervention.

- Advertisement -

Amidst the anti-ageing industry’s shift from consumerism to scientific rigor, Bonerge positions Urolithin A not just as a standalone ingredient, but as a catalyst for evidence-based solutions. Focused on core mechanisms like cellular senescence, Bonerge develops innovative ingredients targeting cellular health, forming a robust “health ecosystem.” Key components include:

Fisetin: Potent senolytic selectively clearing senescent cells and reducing their formation, retarding aging in skin, ovarian, and neural tissues.

Urolithin A: Regulates circadian rhythms, boosts endogenous NAD+ synthesis, enhances cellular repair, and improves sleep quality and reproductive health.

L-Ergothioneine: Unique antioxidant with a dedicated transporter (OCTN1), accumulating in high-stress tissues to neutralize ROS, protecting DNA and telomeres.

PQQ Disodium: Activates the PGC-1α/PPARγ pathway, driving mitochondrial DNA replication and biogenesis.

S–Equol: Natural, non-steroidal estrogenic metabolite with high affinity for ERβ, offering a safer alternative for menopause health.

- Advertisement -

About Bonerge

- Advertisement -

Bonerge firmly contends that the future of anti-ageing hinges on evidence-based solutions. These solutions are grounded in well-defined biological mechanisms, supported by robust scientific data, and tailored to precise applications, ultimately delivering comprehensive, science-validated health benefits. For more detailed information about our clinical findings, discover more about us at http://www.bonerge.com.

Contacts

- Advertisement -

Cecilia Yang

sales@bonerge.com

- Advertisement -
MiTAC Computing Partners with Industry Leaders on Open AI Server Solutions at OCP APAC Summit 2025
KBRA Releases Research Private Credit: Business Development Company (BDC) Ratings Compendium: First-Quarter 2025
Quantexa Named a Luminary in Everest Groups Innovation Watch Report
U-Haul Offers Disaster Relief After Derecho Hits North Dakota, Minnesota
HTX May Performance Report: Trading Volume Surges, Assets Grow Steadily, Rankings Rise Across 6 Major Data Platforms
TAGGED: and forageingaloneassessorsbiologybonergeclinicaldisorderseffectsfisetinhealthcareinitiatedinitiatesinvestigatinglens™nctnewsparticipantsplacebocontrolledprovidersquadrupleblindqualityrandomizedregistrationresearcherssleepstudytargetingtrialurolithinwellbeingwillwireinyorkbusiness
Share This Article
Facebook Copy Link Print
- Advertisement -

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.
FacebookLike
XFollow
PinterestPin
InstagramFollow
YoutubeSubscribe
LinkedInFollow
MediumFollow

Most Selling Products

Top Picks, Trending Now – Discover the Best Sellers!
Tecno Camon 20 Premier 5G

Tecno Camon 20 Premier 5G

Dark Welkin | 8GB RAM + 512GB Storage (Expandable RAM up to 16GB) | Industry’s 1st 50MP RGBW-Pro Camera | Segment-First 108MP Ultra-Wide Macro Lens | 6.67" 120Hz 10-bit AMOLED In-Display

iQOO Z10 Lite 5G

iQOO Z10 Lite 5G

Titanium Blue | 6GB RAM + 128GB Storage | Dimensity 6300 5G with 433K+ AnTuTu Score | Robust 6000mAh Battery | IP64 Rated + Military-Grade Shock Resistance

OnePlus 13s

OnePlus 13s

Black Velvet | 12GB RAM + 256GB Storage | Flagship Snapdragon® 8 Elite Chipset | Exceptional Battery Life in a Compact Form | Lifetime Display Warranty Included

Samsung Galaxy A55 5G

Samsung Galaxy A55 5G

Awesome Iceblue | 8GB RAM + 256GB Storage | Premium Metal Frame | 50MP OIS Main Camera with Nightography | IP67 Water & Dust Resistance | Gorilla Glass Victus+ | sAMOLED Display with Vision Booster

You Might Also Like

Hawaii American Water Granted New Rates by Hawaii Public Utilities Commission
Business

Hawaii American Water Granted New Rates by Hawaii Public Utilities Commission

27/07/2025
Centrum Broking Launches GalaxC – A Unified Investment and Trading Platform
Business

Centrum Broking Launches GalaxC – A Unified Investment and Trading Platform

10/07/2025
Guidelines for Osstem Implants, Implant Fracture and Peripheral Diseases are Presented
Entertainment

Guidelines for Osstem Implants, Implant Fracture and Peripheral Diseases are Presented

06/08/2025

Prime Success Responds to Sinovac Biotechs False and Misleading Claims

14/06/2025
Life Care News
Facebook Twitter Youtube Rss Medium

Life Care News:


We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

Top Categories
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Usefull Links
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Copyright © 2015 – 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Life Care NewsLife Care News
Copyright © 2015 - 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?